QuantHealth

📍 Tel Aviv, Israel🗓 Founded 2020👥 48 employees💰 Last funded Jul 2023
Biotechnology Research🌐 quanthealthlabs.com
Website LinkedIn
QuantHealth is an AI company conducting patient-centric drug simulations to accelerate and de-risk drug development. Over 90% of drugs in clinical development stage fail to reach the market, which accumulates to a $45B/year direct lost to the pharma and biotech industry. Our platform allows our pharma and biotech partners to rapidly run thousands of variations of their clinical trials to optimize the trial design and significantly increase the probability of trial success, all while enabling discovery of new clinical opportunities and optimization strategies. QuantHealth has one the largest integrated datasets that spans the clinical, pharmacological and biological domains together with a proprietary AI platform that can predict patient-response to both approved and novel therapies.
2
Total investors
1
Early stage
1
Mid stage
0
Late stage
2020
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
Israel
1
Germany
1
Frequently asked questions
Who invested in QuantHealth?
QuantHealth has 2 investors on record on gritt.io, including 1 early-stage backers, 1 mid-stage.
When did QuantHealth last raise funding?
The most recent investment in QuantHealth recorded on gritt.io was in July 2023.
When was QuantHealth founded?
QuantHealth was founded in 2020.
What industry is QuantHealth in?
QuantHealth operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is QuantHealth based?
QuantHealth is headquartered in Tel Aviv, Israel.